Adolfo Fernandez Obregon, MD
Dermatology · Hoboken, NJNPI 1316944051
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Pfizer at 29.7% of the total. Reporting peaked in 2023 at $10,929 and has fallen 68.6% since, to $3,434 in 2025. Among dermatology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 751 payments — averaging $50.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$11K
- UCB, Inc.$5K
- Novartis$5K
- Johnson & Johnson$4K
- Lilly USA, LLC$2K
- Amgen$1K
- plus $10K from 30 others
Across 138 payments — averaging $7828.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$286K
- Pfizer$275K
- Sanofi US Services Inc.$264K
- AbbVie$97K
- Novartis$55K
- Genentech, Inc.$23K
- plus $79K from 5 others
What the payments were for
- Consulting fees$6,04516%
- Speaking & faculty fees$12,24532%
- Travel & lodging$6172%
- Food & beverage$18,88950%
- Education$1300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 65 | $11,273 |
| UCB, Inc. | 79 | $5,024 |
| Novartis | 53 | $4,808 |
| Johnson & Johnson | 76 | $3,629 |
| Lilly USA, LLC | 53 | $1,563 |
| Amgen | 49 | $1,440 |
| Sun Pharmaceutical Industries Inc. | 45 | $1,238 |
| AbbVie | 49 | $1,060 |
| E.r. Squibb & Sons, L.L.C. | 20 | $996 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $898 |
| Almirall LLC | 22 | $734 |
| LEO Pharma Inc. | 62 | $656 |
| Incyte Corporation | 18 | $649 |
| Regeneron Healthcare Solutions, Inc. | 8 | $606 |
| Sanofi | 14 | $606 |
| Galderma Laboratories, L.p. | 32 | $566 |
| Mallinckrodt Hospital Products Inc. | 7 | $323 |
| Dermavant Sciences, Inc. | 11 | $262 |
| Janssen Scientific Affairs, LLC | 9 | $262 |
| Journey Medical Corporation | 9 | $250 |
| Boehringer Ingelheim | 4 | $159 |
| Mayne Pharma Commercial LLC | 10 | $132 |
| Kyowa Kirin, Inc. | 1 | $119 |
| Verrica Pharmaceuticals Inc. | 1 | $106 |
| Arcutis Biotherapeutics, Inc. | 7 | $106 |
| Bristol Myers Squibb | 6 | $85 |
| Sebela Pharmaceuticals Inc. | 6 | $79 |
| EPI Health, LLC | 4 | $78 |
| Botanix SB Inc | 3 | $55 |
| Sandoz | 3 | $48 |
| Aclaris Therapeutics, Inc. | 3 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Genentech USA, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $13 |
| Dermira, Inc. | 1 | $13 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,927 in reported general payments places this provider in the 90th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $82,583 |
| Ketoconazole | 251 | $3,200 |
| Fluocinolone Acetonide | 40 | $1,667 |
| Triamcinolone Acetonide | 199 | $1,513 |
| Clobetasol Propionate | 24 | $1,416 |
| Imiquimod | 13 | $1,052 |
| Clindamycin Phosphate | 25 | $611 |
| Ciclopirox | 13 | $601 |
| Fluconazole | 24 | $485 |
| Doxycycline Hyclate | 15 | $329 |
| Ammonium Lactate | 22 | $293 |
| Azathioprine | 13 | $256 |
| Hydrocortisone | 38 | $239 |
| Hydroxyzine Hcl | 16 | $220 |
| Levocetirizine Dihydrochloride | 22 | $132 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hoboken
- Linda Cappiello-LindsleyHoboken$2.3M
- Dina BeganHoboken$14K
- Omar NoorSomerset$4.5M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.